If you have been reading about GHRH analog and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-04-21. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Identity and purity are assessed with reversed-phase high-performance liquid chromatography, which separates the peptide from truncated or oxidized forms. Mass spectrometry confirms the expected molecular weight, and peptide mapping after enzymatic digestion verifies the amino acid sequence. Water content is measured because residual moisture affects stability, and tests for aggregates or particulates are standard for injectable peptides. Circular dichroism can indicate whether the molecule has adopted an unexpected secondary structure in solution.
Research supply is often accompanied by a certificate of analysis listing chromatographic purity, mass confirmation, and storage conditions. Laboratories compare that document with an independent test when material is intended for bench work, since certificates describe a batch rather than an individual vial. Published studies usually state the source and purity of the peptide because small differences in purity can shift measured activity. Full analytical validation is rarely reported, which leaves batch-to-batch comparability an open question.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass and detects chemical modifications. Peptide mapping and amino acid analysis can verify sequence integrity. Water content is measured by Karl Fischer titration, and residual solvents may be checked by gas chromatography. These methods together support batch-to-batch consistency and routine quality control.
Lyophilized tesamorelin is generally stored refrigerated at temperatures between 2 and 8 degrees Celsius. The solid form is comparatively stable when kept dry and protected from light. Moisture uptake can promote aggregation and degradation, so sealed containers with desiccant are common. Researchers typically avoid repeated temperature cycling, which may stress the peptide. Documentation accompanying reference materials usually specifies a shelf life under these conditions.
==== Quorum sensing ==== Quorum sensing is a method that depends on detecting cell or molecule densities to trigger specific responses. As cell density increases, signalling molecule concentrations also increase, eventually reaching a threshold that activates a response. This mechanism is useful to lower functioning costs for bacteria, as this allows high-energy responses to only occur when they are triggered as necessary by the signalling molecule. Known signalling molecules observed in algicidal responses include acyl-homoserine lactones (AHLs), quinolones, and diketopiperazines. Taxa such as Pseudomonas sp., Pseudoalteromonas sp., Vibrio sp., and Alteromonas sp. all demonstrate algicidal activity linked to quorum sensing mechanisms.
In Filipino cuisine, the noodles are called a similar name: sotanghon because of the popular dish of the same name made from them using chicken and wood ears. They are also confused with rice vermicelli, which is called bihon in the Philippines.
== Research directions == Current research and recommendations to manage severe acute malnutrition (SAM), such as kwashiorkor, in children, are largely based on expert opinions. Only one-third of the WHO guidelines for the management of SAM are based on epidemiological and clinical research. Further studies are needed to "improve treatment outcomes in the large number of children with SAM."
=== Psychiatric disorders === Serotonin plays an important role in numerous physiological conditions. 5-HT2 receptor antagonists have long been known, but recently 5-HT2 receptor agonists are becoming promising agents in the development for new antipsychotic drugs. Historically, most pharmacological research on antipsychotic drugs have concentrated on the 5-HT2A receptor subtype. However, recent studies show that agonist activity on 5-HT2A receptors can cause hallucination. Comparison of SSRIs and the 5-HT2C receptor agonists showed that the agonists decreased immobility time and increased swimming time in the FST (forced swim test) in rats in a manner comparable to SSRIs. In the 1990s 5-HT2C receptors have received more attention as many studies have shown that selective 5-HT2C receptor agonists may be more suited in the treatment for psychotic indications. A 5-HT2C agonist may be expected to reduce positive symptoms of schizophrenia by reducing dopamine release in the mesolimbic dopamine pathway. Vabicaserin (SCA-136) is a 5-HT2C agonist that has shown promise in preliminary testing for the treatment of schizophrenia.
Sources: en.wikipedia.org
=== Early life === Dyson was born on 15 December 1923, in Crowthorne in Berkshire, England. He was the son of Mildred (née Atkey) and the composer George Dyson, who was later knighted. His mother had a law degree, and after Dyson was born she worked as a social worker. Dyson had one sibling, his older sister, Alice, who remembered him as a boy surrounded by encyclopaedias and always calculating on sheets of paper. At the age of four he tried to calculate the number of atoms in the Sun. As a child, he showed an interest in large numbers and in the Solar System, and was deeply influenced by Eric Temple Bell's Men of Mathematics (1937). Politically, Dyson said he was "brought up as a socialist". He wrote that "One of my grandmothers was a notorious and successful faith healer. One of my cousins was for many years the editor of the Journal of the Society for Psychical Research. Both of these ladies were well educated, highly intelligent, and fervent universelle in paranormal phenomenon. They may have been deluded, but neither of them was a fool." From 1936 to 1941 Dyson was a scholar at Winchester College, where his father was Director of Music. At the age of 17 he studied pure mathematics with Abram Besicovitch as his tutor at Trinity College, Cambridge, where he won a scholarship at age 15. During this stay, Dyson also practised night climbing on the university buildings, and once walked from Cambridge to London in a day with his friend Oscar Hahn, nephew of Kurt Hahn, who was a wheelchair user due to polio.
===== MeSH D08.811.913.400 – glycosyltransferases (EC 2.4) ===== MeSH D08.811.913.400.100 – n-acetylhexosaminyltransferases MeSH D08.811.913.400.100.200 – n-acetylgalactosaminyltransferases MeSH D08.811.913.400.100.200.300 – fucosyl galactose alpha-n-acetylgalactosaminyltransferase MeSH D08.811.913.400.100.250 – n-acetylglucosaminyltransferases MeSH D08.811.913.400.450 – hexosyltransferases MeSH D08.811.913.400.450.300 – fucosyltransferases MeSH D08.811.913.400.450.400 – galactosyltransferases MeSH D08.811.913.400.450.400.100 – n-acylsphingosine galactosyltransferase MeSH D08.811.913.400.450.400.450 – beta-n-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase MeSH D08.811.913.400.450.400.475 – ganglioside galactosyltransferase MeSH D08.811.913.400.450.400.500 – lactose synthase MeSH D08.811.913.400.450.400.500.100 – n-acetyllactosamine synthase MeSH D08.811.913.400.450.460 – glucosyltransferases MeSH D08.811.913.400.450.460.100 – 1,4-alpha-glucan branching enzyme MeSH D08.811.913.400.450.460.200 – chitin synthase MeSH D08.811.913.400.450.460.350 – glycogen debranching enzyme system MeSH D08.811.913.400.450.460.375 – glycogen synthase MeSH D08.811.913.400.450.460.400 – phosphorylases MeSH D08.811.913.400.450.460.400.186 – glycogen phosphorylase MeSH D08.811.913.400.450.460.400.186.061 – glycogen phosphorylase, brain form MeSH D08.811.913.400.450.460.400.186.124 – glycogen phosphorylase, liver form MeSH D08.811.913.400.450.460.400.186.312 – glycogen phosphorylase, muscle form MeSH D08.811.913.400.450.460.400.280 – phosphorylase a MeSH D08.811.913.400.450.460.400.327 – phosphorylase b MeSH D08.811.913.400.450.460.400.374 – starch phosphorylase MeSH D08.811.913.400.450.460.750 – starch synthase MeSH D08.811.913.400.450.480 – glucuronosyltransferase MeSH D08.811.913.400.450.560 – mannosyltransferases MeSH D08.811.913.400.450.780 – peptidoglycan glycosyltransferase MeSH D08.811.913.400.725 – pentosyltransferases MeSH D08.811.913.400.725.100 – adenine phosphoribosyltransferase MeSH D08.811.913.400.725.115 – adp ribose transferases MeSH D08.811.913.400.725.115.180 – cholera toxin MeSH D08.811.913.400.725.115.220 – diphtheria toxin MeSH D08.811.913.400.725.115.660 – nad+ nucleosidase MeSH D08.811.913.400.725.115.660.060 – adp-ribosyl cyclase MeSH D08.811.913.400.725.115.680 – pertussis toxin MeSH D08.811.913.400.725.115.690 – poly(adp-ribose) polymerases MeSH D08.811.913.400.725.115.690.840 – tankyrases MeSH D08.811.913.400.725.115.845 – sirtuins MeSH D08.811.913.400.725.130 – amidophosphoribosyltransferase MeSH D08.811.913.400.725.160 – anthranilate phosphoribosyltransferase MeSH D08.811.913.400.725.200 – ATP phosphoribosyltransferase MeSH D08.811.913.400.725.450 – hypoxanthine phosphoribosyltransferase MeSH D08.811.913.400.725.700 – orotate phosphoribosyltransferase MeSH D08.811.913.400.725.800 – purine-nucleoside phosphorylase MeSH D08.811.913.400.725.900 – thymidine phosphorylase MeSH D08.811.913.400.725.950 – uridine phosphorylase MeSH D08.811.913.400.800 – sialyltransferases
== Integrated strategy for functional assignment == The EFI is developing an integrated sequence-structure based strategy for functional assignment by predicting the substrate specificities of unknown members of mechanistically diverse enzyme superfamilies. The approach leverages conserved features within a given superfamily such as known chemistry, identity of active site functional groups, and composition of specificity-determining residues, motifs, or structures to predict function but relies on multidisciplinary expertise to streamline, refine, and test the predictions. The integrated sequence-strategy under development will be generally applicable to deciphering the ligand specificities of any functionally unknown protein.
=== Hydrogen Isotope Analysis === Hydrogen isotope analysis is used to help reconstruct environmental change. Dinosterol is a particularly good target for such analysis because it is commonly found in high concentrations in a variety of aquatic environments and is well preserved in the sediment record. Hydrogen isotope analysis requires a purification method that achieves GC baseline resolution and is high yielding. Dinosterol coelutes with other sterols during GC; therefore a procedure for proper purification that involves reversed phase-high performance liquid chromatography (RP-HPLC) was developed by Atwood et al. The hydrogen isotope ratios in dinosterol can be used to reconstruct salinity semi-quantitatively. In a study by Schwab et al., the hydrogen isotope ratio of dinosterol was measured in suspended particles and surface sediments from the Chesapeake Bay estuary. The D/H ratio was found to decrease by 0.99 ± 0.23% per unit increase in salinity over the salinity range 10–29 PSU. The correlation between hydrogen isotopic response and salinity may result from diminished exchange of water between algal cells and their environment, lower growth rates and/or increased production of osmolytes at high salinities.
== U == UbiD protein domain - ubiquitin—calmodulin ligase - UDP-3-O-N-acetylglucosamine deacetylase - UDP-4-amino-4,6-dideoxy-N-acetyl-alpha-D-glucosamine transaminase - undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase - untranslated RNA - upstream - upstream activator sequence - upstream DNA - upstream (transduction) - uracil - uracil/thymine dehydrogenase - ureidoglycolate hydrolase -
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
Lyophilized material is typically kept refrigerated and away from light in the sealed vial provided. Dissolved material is generally used within a limited period rather than stored long term.